Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | ShortHER study: validating the AJCC prognostic stage in HER2+ breast cancer

Maria Vittoria Dieci, MD, of the University of Padua, Padova, Italy, describes the results of the ShortHER study (NCT00629278) which aimed to validate the introduction of prognostic staging in the American Joint Committee on Cancer (AJCC) guidelines. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).